Abstract:Background: ERK5 has been demonstrated to be related to survival, growth, and differentiation of cancer cells. However, the function of ERK5 signaling in cancer metastasis has not been fully elucidated. This study was designed to ascertain the involvement of ERK5 signaling in lung cancer and melanoma metastasis process.Methods: The involvement of ERK5 in cancer metastasis was assessed on various cancer cell lines by wound-healing, transwell, immunofluorescence, and in vivo melanoma lung metastasis assays. High-content proteomics screen in combination with MetacoreTM GeneGo pathway analysis were performed to identify key signaling pathways regulated by ERK5, which is associated with cancer metastasis.Findings: Our data showed that ERK5 expression is abundant in human lung cancer samples, where elevated ERK5 expression related to the acquisition of more metastatic and invasive potential. Importantly, we observed a significant correlation between ERK5 activity and FAK expression and its phosphorylation at Ser910 site. Mechanistically, ERK5 increased the expression of transcription factor USF1, which could transcriptionally up-regulate FAK expression, resulting in FAK signaling activation to promote cell migration. We also provided evidence that the phosphorylation of Ser910 of FAK was due to ERK5 but not ERK1/2, and suggested a role for Ser910 in the control of cell motility. In addition, ERK5 had more targets other than FAK to regulate epithelial-to-mesenchymal transition and cell motility in cancer cells.Interpretation: Our findings uncover a cancer metastasis-promoting role of ERK5 and provide the rationale for targeting ERK5 as a potential therapeutic approach.Funding Statement: Chinese National Natural Sciences Foundation (81773099, 81570790).Declaration of Interests: The authors declare no potential conflicts of interest.Ethics Approval Statement: Animal welfare and experimental procedures were performed strictly in accordance with high standard animal welfare and other related ethical regulations approved by Nanjing University.

MFAP5 Promotes Tumor Progression and Bone Metastasis by Regulating ERK/MMP Signaling Pathways in Breast Cancer.

MFAP5 in Cancer-associated Fibroblasts Regulates the Progression of the PDAC

CAFs-derived MFAP5 Promotes Bladder Cancer Malignant Behavior Through NOTCH2/HEY1 Signaling.

The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects

The role of microfibrillar‐associated protein 2 in cancer

FAP promotes metastasis and chemoresistance via regulating YAP1 and macrophages in mucinous colorectal adenocarcinoma

Upregulation of MFAP5 Enhances COL1A1 Expression, Promoting Epithelial-Mesenchymal Transition in Gastric Cancer Cells

Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix

MFAP3L Activation Promotes Colorectal Cancer Cell Invasion and Metastasis

Δef1 Promotes Osteolytic Metastasis of MDA-MB-231 Breast Cancer Cells by Regulating MMP-1 Expression.

TGF-β1-activated Cancer-Associated Fibroblasts Promote Breast Cancer Invasion, Metastasis and Epithelial-Mesenchymal Transition by Autophagy or Overexpression of FAP-α

Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer

MFAP2 Promotes the Progression of Oral Squamous Cell Carcinoma by Activating the Wnt/β-catenin Signaling Pathway Through Autophagy.

Upregulation of MEK5 by Stat3 Promotes Breast Cancer Cell Invasion and Metastasis.

Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner

Integrated Analysis of Microfibrillar-Associated Proteins Reveals MFAP4 As a Novel Biomarker in Human Cancers

Extracellular Signal Regulated Kinase 5 Promotes Cell Migration, Invasion and Lung Metastasis Through a FAK-Dependent Manner

Autocrine Motility Factor Promotes Epithelial-Mesenchymal Transition in Endometrial Cancer Via MAPK Signaling Pathway.

MFAP2 is Overexpressed in Gastric Cancer and Promotes Motility Via the MFAP2/integrin Α5β1/fak/erk Pathway.

FYN Promotes Breast Cancer Progression Through Epithelial-Mesenchymal Transition.

Cancer-associated fibroblasts support bone tropic metastasis by acting as coordinators between the tumor microenvironment and bone matrix in breast cancer.